The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT

被引:270
作者
Huynh, KD
Bardwell, VJ
机构
[1] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Biochem Mol Biol & Biophys Program, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA
关键词
POZ domain; BCL-6; transcriptional repression; N-CoR; SMRT;
D O I
10.1038/sj.onc.1202197
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Virtually all diffuse large cell lymphomas and a significant fraction of follicular lymphomas contain translocations and/or point mutations in the 5' noncoding region of the putative oncogene BCL-6, that are presumed to deregulate its expression. BCL-6 encodes a Cys(2)-His(2) zinc finger transcriptional repressor with a POZ domain at its amino-terminus, The POZ (or BTB) domain, a 120-amino-acid motif, mediates homomeric and, in some proteins, heteromeric POZ-POZ interactions. In addition, the POZ domain is required for transcriptional repression of several proteins, including BCL-6, Using a yeast two-hybrid screen, we identified N-CoR and SMRT as BCL-6 interacting proteins. Both N-CoR and SMRT, which were originally identified as co-repressors for the unliganded nuclear thyroid hormone and retinoic acid receptors, are components of large complexes containing histone deacetylases, We show that the interaction between BCL-6 and these co-repressors is also detected in the more physiologically relevant mammalian two-hybrid assay. The POZ domain is necessary and sufficient for interaction with these corepressors. BCL-6 and N-CoR co-localize to punctate regions of the nucleus. Furthermore, when BCL-6 is bound to its consensus recognition sequence in vivo, it can interact with N-CoR and SMRT, We find, in vitro, that POZ domains from a variety of other POZ domain-containing proteins, including the transcriptional repressor PLZF, as well as ZID, GAGA and a vaccinia virus protein, SalF17R, also interact with varying affinities with N-CoR and SMRT, We find that BCL-6 POZ domain mutations that disrupt the interaction with N-CoR and SMRT no longer repress transcription. In addition, these mutations no longer self associate suggesting that self interaction is required for interaction with the co-repressors and for repression. More recently N-CoR has also been implicated in transcriptional repression by the Mad/Mxi proteins. Our demonstration that N-CoR and SMRT interact with the POZ domain containing proteins indicates that these co-repressors are likely involved in the mediation of repression by multiple classes of repressors and may explain, in part, how POZ domain containing repressors mediate transcriptional repression.
引用
收藏
页码:2473 / 2484
页数:12
相关论文
共 74 条
[41]   Role of the histone deacetylase complex in acute promyelocytic leukaemia [J].
Lin, RJ ;
Nagy, L ;
Inoue, S ;
Shao, WL ;
Miller, WH ;
Evans, RM .
NATURE, 1998, 391 (6669) :811-814
[42]   Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma [J].
Migliazza, A ;
Martinotti, S ;
Chen, WY ;
Fusco, C ;
Ye, BH ;
Knowles, DM ;
Offit, K ;
Chaganti, RSK ;
DallaFavera, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :12520-12524
[43]  
MIKI T, 1994, BLOOD, V83, P217
[44]   PEF-BOS, A POWERFUL MAMMALIAN EXPRESSION VECTOR [J].
MIZUSHIMA, S ;
NAGATA, S .
NUCLEIC ACIDS RESEARCH, 1990, 18 (17) :5322-5322
[45]   Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase [J].
Nagy, L ;
Kao, HY ;
Chakravarti, D ;
Lin, RJ ;
Hassig, CA ;
Ayer, DE ;
Schreiber, SL ;
Evans, RM .
CELL, 1997, 89 (03) :373-380
[46]   TRANSCRIPTIONAL REPRESSOR ZF5 IDENTIFIES A NEW CONSERVED DOMAIN IN ZINC-FINGER PROTEINS [J].
NUMOTO, M ;
NIWA, O ;
KAPLAN, J ;
WONG, KK ;
MERRELL, K ;
KAMIYA, K ;
YANAGIHARA, K ;
CALAME, K .
NUCLEIC ACIDS RESEARCH, 1993, 21 (16) :3767-3775
[47]   REARRANGEMENT OF THE BCL-6 GENE AS A PROGNOSTIC MARKER IN DIFFUSE LARGE-CELL LYMPHOMA [J].
OFFIT, K ;
LOCOCO, F ;
LOUIE, DC ;
PARSA, NZ ;
LEUNG, D ;
PORTLOCK, C ;
YE, BH ;
LISTA, F ;
FILIPPA, DA ;
ROSENBAUM, A ;
LADANYI, M ;
JHANWAR, S ;
DALLAFAVERA, R ;
CHAGANTI, RSK .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (02) :74-80
[48]   HETEROGENEITY IN B-CELL NEOPLASMS ASSOCIATED WITH REARRANGEMENT OF THE LAZ3 GENE ON CHROMOSOME BAND 3Q27 [J].
OHNO, H ;
KERCKAERT, JP ;
BASTARD, C ;
FUKUHARA, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (06) :592-600
[49]   BCL-6 GENE-PRODUCT, A 92-KD TO 98-KD NUCLEAR PHOSPHOPROTEIN, IS HIGHLY EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS [J].
ONIZUKA, T ;
MORIYAMA, M ;
YAMOCHI, T ;
KURODA, T ;
KAZAMA, A ;
KANAZAWA, N ;
SATO, K ;
KATO, T ;
OTA, H ;
MORI, S .
BLOOD, 1995, 86 (01) :28-37
[50]   ANALYSIS OF LAZ3 (BCL-6) STATUS IN B-CELL NON-HODGKINS-LYMPHOMAS - RESULTS OF REARRANGEMENT AND GENE-EXPRESSION STUDIES AND A MUTATIONAL ANALYSIS OF CODING REGION SEQUENCES [J].
OTSUKI, T ;
YANO, T ;
CLARK, HM ;
BASTARD, C ;
KERCKAERT, JP ;
JAFFE, ES ;
RAFFELD, M .
BLOOD, 1995, 85 (10) :2877-2884